What's fair: ICER re­port finds in­sur­er cov­er­age typ­i­cal­ly meets ac­cess cri­te­ria for 18 pre­scrip­tion drugs

Drug pric­ing watch­dog ICER on Fri­day un­veiled its third an­nu­al score­card on how “fair­ly” sev­er­al US in­sur­ers and PBMs cov­ered 18 pre­scrip­tion drugs across 19 for­mu­la­ries in 2021, find­ing a “high de­gree of align­ment” be­tween in­sur­ance poli­cies and ICER’s fair ac­cess cri­te­ria.

“While the ev­i­dence avail­able and the lim­i­ta­tions of our re­search ef­fort leave many ques­tions, our re­sults demon­strate that the ma­jor­i­ty of pay­er poli­cies in the for­mu­la­ries eval­u­at­ed are struc­tured in a way to sup­port many key el­e­ments of fair ac­cess,” the group said in the re­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER